Services
Product Development
Our Science
About
Contact
Investors archive

Services

Progress your programme with our unique combination of inhaled development expertise, formulation science and device technology. We offer a fully-integrated approach to support you in the development of your inhaled medicine.

Services

Development

FormulationPharmaceutical analysisDevice platforms

Manufacturing

Process development & technical transferProduct manufacturing

Regulatory

Regulatory Services

About

Inhalation is our focus. With more than 20 years’ experience, we can help you succeed in bringing inhaled medicines to market.

About

Updates

News

About Vectura

Track RecordLeadership team

Financial Information

PMI OfferMeetings & Voting

Investors archive

The information displayed in this section is historical information.

Investors archive

Stocks

RNS updates

Shareholders

Shareholder informationAnalyst coverage

Reports

Financial reports and presentations

Investors

Investment caseGovernance

Investors archive

The information displayed in this section is historical information.

Acquisition offer

Vectura Group Annual Report and Accounts for 2020

Cash offer by Philip Morris International.

Vectura Group Annual Report and Accounts for 2020

Services
Product Development
Our Science
About
Contact
Investors archive

Careers

Vectura Fertin Pharma
Accessibility
Commitment to inclusivity
Modern Slavery Act
Gender pay gap
Supplier Terms and Conditions
Tax strategy
Privacy policy
Website Terms & Conditions
Cookie Statement
Site map
Breelib™ Instructions for Use
FOX^® Mobile Instructions for use
AKITA^® JET Inhalation System Instructions for Use

Designed and Developed by Naked Ideas